加拿大多伦多消息:多伦多大学临床生化学家发明了用胶囊包裹环孢素的方法,这种环孢素药效强、毒性小。在人工膜的蛋白-脂质相互作用的研究中,Nikola Stanacev及其研究小组发现,可用脂质体包裹强效免疫抑制剂。已知脂质和蛋白可以在脂质体内结合。这种环孢素会更有效的被人体利用,可以用更小的剂量,减少药物的毒性作用。尚需进一步研究,以测定此种环孢素的利用率和毒性。脂质型环孢素的物理和化学特性有很大的改变;含环孢素的脂质 TORONTO, CANTON: Clinical biochemists at the University of Toronto have invented a method of encapsulating cyclosporine in capsules that are highly potent and less toxic. In the study of the protein-lipid interaction of artificial membranes, Nikola Stanacev and his team found that liposomes can be potent potent immunosuppressants. Lipids and proteins are known to bind within liposomes. This cyclosporin will be more effective use of the human body, you can use a smaller dose, reduce the toxic effects of drugs. Further studies are needed to determine the availability and toxicity of this cyclosporin. The physical and chemical properties of liposomal cyclosporins vary greatly; cyclosporine-containing lipids